Lavender Aromatherapy Trial for Cognitive Function in Older Adults with MCI
A clinical trial is underway to evaluate the effects of lavender aromatherapy on cognitive function in older adults with Mild Cognitive Impairment.
Phase III
Neurology / Cognitive Impairment
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial of lavender aromatherapy for cognitive function in older adults with Mild Cognitive Impairment (MCI) could reshape treatment approaches in neurology. A successful outcome may lead to increased adoption of non-pharmacological interventions, impacting product development and market strategies in the cognitive health sector.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent publications or follow-up studies that may validate the efficacy of lavender aromatherapy.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.